MXCT MaxCyte, Inc.

1.040USD-4.59%Mkt Cap: 107.33M $P/E: —

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrume…

Key Statistics

Company
Market Cap107.33M USD
Enterprise Value24.06M USD
Revenue (TTM)31.05M USD
Gross Profit26.80M USD
Net Income (TTM)-44.63M USD
Revenue/Share0.29 USD
Last Price1.040 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees91
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.44
PEG—
EV/EBITDA-0.79
EV/Revenue0.77
P/S3.62
P/B0.73
EPS (TTM)-0.34
EPS (Forward)-0.25
52W Range
0.643032% of range1.865
52W High1.865 USD
52W Low0.6430 USD
Profitability
Gross Margin81.16%
Oper. Margin-140.72%
EBITDA Margin-97.54%
Profit Margin-135.14%
ROE-26.02%
ROA-22.04%
Growth
Revenue Growth-14.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-34.41M USD
CapEx (TTM)1.77M USD
FCF Margin-42.31%
FCF Yield-12.24%
Net Debt-88.44M USD
Net Debt/EBITDA2.92
Balance Sheet
Debt/Equity0.10
Current Ratio12.26
Quick Ratio11.08
Book Value/Sh1.50 USD
Cash/Share1.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.107 USD
Upside (mean)+295.0%
Target Range2.430 USD – 5.000 USD
2.430+295.0% to mean5.000
# Analysts4
Ownership
Shares Out.103.21M
Float93.72M
Insiders1.84%
Institutions62.00%
Short Interest
Short Ratio2.4d
Short % Float1.15%
Short % Out.1.13%
Shares Short1.17M
Short (prev mo.)1.23M
Technical
SMA 501.205 (-13.7%)
SMA 2001.080 (-3.7%)
Beta1.49
S&P 52W Chg16.45%
Avg Vol (30d)417.28K
Avg Vol (10d)315.32K
Technical Indicators
RSI (14)33.0
MACD-0.0420
MACD Signal-0.0275
MACD Hist.-0.0145
BB Upper1.285 USD
BB Middle1.162 USD
BB Lower1.039 USD
BB Width21.23%
ATR (14)0.0593 USD
Vol Ratio (20d)0.88x